-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
-
Summary
-
InMed Pharmaceuticals Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from 2020 to 2024.
- InMed Pharmaceuticals Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending September 30, 2024 was 620K shares, a 273% increase year-over-year.
- InMed Pharmaceuticals Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2024 was 7.62M shares, a 211% increase from 2023.
- InMed Pharmaceuticals Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 2.45M shares, a 337% increase from 2022.
- InMed Pharmaceuticals Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 561K shares, a 109% increase from 2021.
Weighted Average Number of Shares Outstanding, Diluted, Annual (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Annual Growth (%)